logo

For the Inventor, By the Inventor

Nottingham, United Kingdom

Scancell Limited


USPTO Granted Patents = 12

% Expired Patents = 8.3



Trademarks = 4

Forward Citations = 11

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Linda Gillian Durrant (11 out of 16 patents)

silverMedal Victoria Anne Brentville (5 out of 5 patents)

bronzeMedal Tina Parsons (3 out of 9 patents)

4.  Rachael Louise Metheringham (3 out of 3 patents)

5.  Rachel Louise Metheringham (2 out of 2 patents)

6.  Mireille Vankemmelbeke (2 out of 3 patents)

7.  Victoria Anne Pudney (1 out of 1 patent)

8.  Adrian Robins (1 out of 1 patent)

9.  Frank Carr (1 out of 1 patent)

10.  Wei Xue (1 out of 1 patent)

11.  Katherine Wendy Cook (1 out of 1 patent)

12.  Lindy Gillian Durrant (3 patents)

13.  Silvana Tivadar (1 patent)

14.  Richard McIntosh (1 patent)


12 patents:

1. 12643956 - BINDING MEMBERS (2026-06-02),
2. 12595313 - MODIFIED FC-REGIONS TO ENHANCE FUNCTIONAL AFFINITY OF ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF (2026-04-07),
3. 12552876 - ANTI-FUCOSYL-GM1 ANTIBODIES (2026-02-17),
4. 12458688 - Epitopes (2025-11-04),
5. 12258377 - Anti-tumour response to modified self-epitopes (2025-03-25),
6. 11382985 - Anti-tumour immune responses to modified self-epitopes (2022-07-12),
7. 10695438 - Anti-tumour immune responses to modified self-epitopes (2020-06-30),
8. 10233220 - Anti-tumour response to modified self-epitopes (2019-03-19),
9. 8742088 - Nucleic acids encoding antibodies or portions thereof comprising a heterologous T cell epitope and their use in modulating T cell responses (2014-06-03),
10. 8187600 - Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses (2012-05-29),
11. 7267821 - [object Object] (2007-09-11),
12. 6258528 - Signal amplification method (2001-07-10),
Company Overview
Scancell Limited is a biotechnology company based in Nottingham, UK, specializing in the development of innovative immunotherapies for the treatment of cancer. The company focuses on harnessing the body's immune system to target and destroy cancer cells, with a strong emphasis on novel therapeutic approaches. Scancell's research encompasses various domains, including monoclonal antibodies and vaccine development, aiming to improve patient outcomes through advanced cancer treatments.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#14 in Nottingham

#1,458 in United Kingdom

#48,163 in the World

Nottingham, GB
Nottingham, United Kingdom

Scancell Limited

Forward Citations = 11

9 inventors:

goldMedal Linda Gillian Durrant (11 out of 16 patents)

silverMedal Victoria Anne Brentville (5 out of 5 patents)

bronzeMedal Tina Parsons (3 out of 9 patents)

4.  Rachael Louise Metheringham (3 out of 3 patents)

5.  Rachel Louise Metheringham (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scancell Limited. Retrieved from https://idiyas.com/company/scancell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…